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Abstract Efficient mitochondrial function is required in tissues with high energy demand such as
the heart, and mitochondrial dysfunction is associated with cardiovascular disease. Expression of
mitochondrial proteins is tightly regulated in response to internal and external stimuli. Here we
identify a novel mechanism regulating mitochondrial content and function, through BUD23-
dependent ribosome generation. BUD23 was required for ribosome maturation, normal 18S/28S
stoichiometry and modulated the translation of mitochondrial transcripts in human A549 cells.
Deletion of Bud23 in murine cardiomyocytes reduced mitochondrial content and function, leading
to severe cardiomyopathy and death. We discovered that BUD23 selectively promotes ribosomal
interaction with low GC-content 5’UTRs. Taken together we identify a critical role for BUD23 in
bioenergetics gene expression, by promoting efficient translation of mRNA transcripts with low
5’UTR GC content. BUD23 emerges as essential to mouse development, and to postnatal cardiac
function.
Introduction
Regulation of protein abundance within a cell is of fundamental importance to homeostasis, cell
identity and responsiveness to changes in external environment. Many layers of regulatory control
have evolved to fine-tune gene expression to meet cellular needs, including transcriptional regula-
tion, cis-acting genomic elements, epigenetic structures, and translational efficiency. Selective con-
trol of mRNA translation at the level of the ribosome is emerging as important for protein dynamics
within the cell; however, the regulatory mechanisms remain unclear (Sonenberg and Hinnebusch,
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2009). Protein synthesis is the most energetically-demanding process for a cell to perform and,
therefore, mRNA translation is closely coupled to mitochondrial function (Morita et al., 2013).
Mitochondria are fundamental cellular components of eukaryotes, generating the majority of cel-
lular ATP. The human mitochondrial genome contains only 37 genes, of which 13 are subunits of
respiratory complexes, 22 encode mitochondrial tRNAs, and a further two encode rRNA. Whilst the
mitochondrion translates the 13 protein-coding genes of its own genome using a bespoke mitochon-
drial apparatus, the majority of the genes required for a functional mitochondrion are encoded in
the cell nuclear genome and are, therefore, dependent on the cytosolic translational apparatus. This
relationship implies a fundamental role for the eukaryotic 80S ribosome in control of mitochondrial
abundance and function. Indeed, mitochondrial content and function varies between tissues and
cell-types, as well as within a tissue, in response to external and internal stimuli including energy
demand, oxidative stress and cellular signals (Palmer et al., 2011). For example, red blood cells con-
tain no mitochondria whereas in cardiomyocytes mitochondria occupy 30% of cell volume to meet
the exceptionally high ATP demand (Piquereau et al., 2013). Mitochondrial dysfunction has been
linked to a wide range of cardiac disorders, often due to the aberrant production of ROS, and atten-
dant cell death (Kanaan and Harper, 2017; Ott et al., 2007).
BUD23 (previously known as WBSCR22) was initially identified as a putative methyltransferase
implicated in tumour metastases (Nakazawa et al., 2011). Its expression is responsive to diverse
inflammatory and cancer pathologies (Jangani et al., 2014), and reduction of BUD23 expression can
affect cellular response to glucocorticoid and alter histone methylation (Jangani et al., 2014). How-
ever, BUD23 actions were diverse, and a unifying mechanism of action was elusive. More recent
studies identified ribosomal RNA as the preferred substrate of BUD23 (Haag et al., 2015;
White et al., 2008; Zorbas et al., 2015). There is little understanding of the physiological role of
BUD23 in a mammalian context although it is one of the genes deleted in Williams-Beuren syndrome
(WBS). WBS patients have a complex phenotype with prominent neurological and morphological
features. In addition metabolic pathologies exist including diabetes and obesity (Morris, 1993). The
contribution of individual genes within the 22-gene interval to the human phenotype has not been
determined, but the neurological and metabolic features suggest a bioenergetic contribution.
eLife digest Cells need to make proteins to survive, so they have protein-making machines
called ribosomes. Ribosomes are themselves made out of proteins and RNA (a molecule similar to
DNA), and they are assembled by other proteins that bring ribosomal components together and
modify them until the ribosomes are functional.
Mitochondria are compartments in the cell that are in charge of providing it with energy. To do
this they require several proteins produced by the ribosomes. If not enough mitochondrial proteins
are made, mitochondria cannot provide enough energy for the cell to survive.
One of the proteins involved in modifying ribosomes so they are functional is called BUD23.
People with certain diseases, such as Williams-Beuren syndrome, do not make enough BUD23; but it
was unknown what specific effects resulted from a loss of BUD23.
To answer this question, Baxter et al. first genetically removed BUD23 from human cells, and
then checked what happened to protein production. They found that ribosomes in human cells with
no BUD23 were different than in normal cells, and that cells without BUD23 produced different
proteins, which did not always perform their roles correctly. Proteins in the mitochondria are one of
the main groups affected by the absence of BUD23. To determine what effects these modified
mitochondrial proteins would have in an animal, Baxter et al. genetically modified mice so that they
no longer produced BUD23. These mice developed heart problems caused by their mitochondria
not working correctly and being unable to provide the energy the heart cells needed, eventually
leading to heart failure. Heart problems are common in people with Williams-Beuren syndrome.
Many diseases arise when a person’s mitochondria do not work properly, but it is often unclear
why. These experiments suggest that low levels of BUD23 or faulty ribosomes may be causing
mitochondria to work poorly in some of these diseases, which could lead to the development of new
therapies.
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BUD23 is a ribosomal RNA methyltransferase which imparts a methyl mark on a key guanosine
residue (forming N7-methylguanosine) located between the E and P site of the small ribosomal sub-
unit that has been mapped to residue G1575 of yeast 18S rRNA and G1639 of human 18S rRNA
(Haag et al., 2015; O˜unap et al., 2013; White et al., 2008; Zorbas et al., 2015). BUD23 protein is
found in both the nucleus and the cytoplasm (O˜unap et al., 2015), and its depletion leads to a
nuclear accumulation of 18SE-pre-RNA (Haag et al., 2015). In both yeast and human cells the meth-
yltransferase catalytic activity of BUD23 is not required for the processing of 18S pre-RNA, or the
synthesis of 40S subunits, indicating that BUD23 has an additional role, distinct from its methyltrans-
ferase activity (Haag et al., 2015; Zorbas et al., 2015).
In human cell lines it has been suggested that some 18S rRNA lacks the m7-G1639 mark, which
may indicate a selective role in ribosome function (Haag et al., 2015). BUD23 stability requires inter-
action with TRMT112 (TRM112 in yeast), an obligate binding partner, which is known to stabilise
four client methyltransferase enzymes, all involved in the generation of the translational apparatus
(Bourgeois et al., 2017; Le´toquart et al., 2014). The binding of TRMT112 with these four methyl-
transferases is competitive, which results in tight regulation of BUD23 protein concentration and
enzymatic function at the level of protein stability.
Here we identify a novel mechanism linking the energy-demanding process of protein translation
to mitochondrial dynamics through BUD23. We examine the role of BUD23 in ribosome function and
discover that BUD23 preferentially promotes the selection of mRNA species with low GC-content
5’UTRs. We also identify a role for BUD23 in mitochondrial transcript translation which impacts mito-
chondrial function in vitro. We go on to examine the role of BUD23 in a murine in vivo system and
discover that the production of mitochondrial proteins is dependent on BUD23. Finally, we examine
the role of BUD23 in the mitochondrially-rich and energetically-demanding cardiac tissue and dis-
cover a cardiomyopathy phenotype leading to premature death. These discoveries identify BUD23
as essential for mammalian mitochondrial function, with implications for human mitochondrial dis-
ease and cardiomyopathy.
Results
BUD23 plays a major role in translational homeostasis
We previously identified pleiotropic actions of BUD23 in airway epithelial cells, and attributed these
to an epigenetic effect (Jangani et al., 2014). The discovery that BUD23 modifies ribosomal RNA
rather than histone proteins prompted re-examination of the BUD23 role in physiology. To identify
candidate pathways affected by BUD23 we depleted expression in human airway epithelial cells
(Figure 1A,B). This intervention caused a small but statistically significant decrease in cell prolifera-
tion (Figure 1C), which is similar to the anti-proliferative effects caused by BUD23 deletion in yeast
(White et al., 2008).
To investigate comprehensively the role of BUD23 in ribosome function we performed polysome
profiling. The 48 hr knockdown of BUD23 resulted in a reduction of the 40S subunit peak, and a con-
comitant increase in the 60/80S peak (Figure 1D,E). There was, however, little change in the profile
of the polysome fractions at this early time-point following transient BUD23 knockdown, allowing us
to investigate the changes in mRNA substrate selection in the intact polysomes. To test the global
efficiency of the translational apparatus in cells lacking BUD23, we used 35-S-methionine incorpo-
ration for 1 hr (Figure 1—figure supplement 1). This demonstrated little overall impact on global
protein translation rate, confirming that the identified polysomes were essentially competent at this
time-point, despite the impact on 40S maturation. In order to determine if BUD23-loss differentially
impacted the translation of a specific subset of mRNAs, we profiled the translational efficiency (TE)
of individual mRNA species within the polysome profiles.
To do this, the polysome fractions were divided into ‘heavy’ (more than three ribosomes) or ‘light’
(less than three ribosomes) and pooled, prior to RNA extraction and sequencing. This defined a total
of 14,527 transcripts, from which the relative proportion of each individual transcript in the heavy
compared to the light fraction was calculated to give a translation efficiency (TE) score. Average TE
scores across the three replicates for each condition (+ /- BUD23) were then plotted against each
other (Figure 1F). This revealed that the most efficiently translated transcripts in the control samples
(more heavily loaded with ribosomes), were most significantly reduced in the BUD23 knockdown
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Figure 1. Analysis of BUD23-dependent ribosome function. (A) Relative mRNA expression levels of BUD23. A549 cells were transfected for 48 hr with
either BUD23 specific siRNA (si29, 30, 31) or non-targeting control (neg1, 2). Total RNA was extracted before reverse transcription to cDNA and qPCR
(TaqMan). (B) Protein expression was determined by western blotting using antibody GTX105840. Actin was used as a loading control. (C) siRNA
treated cells were plated into cell culture wells and allowed to grow in DMEM supplemented with 10% FBS for 48 hr. Total cell volume was then
Figure 1 continued on next page
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condition. To examine the identity of the most highly affected transcripts, a threshold of >1 or <-1
difference in the relative TE was set (i.e. TE doubled or halved), and applied to Figure 1F, shown as
trend lines. There were 650 transcripts with a TE ratio <-1 and 95 transcripts where the TE ratio >1
after BUD23 depletion; indicating the marked loss of high efficiency mRNA translation.
Analysis of BUD23 differentially translated mRNA species
The 650 transcripts for which TE was reduced (TE ratio <-1 after BUD23 depletion) constituted a
highly connected network, with a significantly higher number of protein-protein interactions than
would be expected from a random dataset of similar size, and an interaction analysis (PPI) enrich-
ment p-value<1e 16. Gene set analysis of these transcripts revealed enrichment for genes involved
in RNA processing, metabolic processes and organelle organisation among other high energy
demand processes (Figure 1—figure supplement 1).
Surprisingly, the TE of mitochondrially-encoded transcripts was observed to be particularly
strongly down-regulated (Figure 1G). In fact, all mitochondrial transcripts had a negative change in
TE after BUD23 loss, with approximately 50% reduction in TE.
BUD23 expression promotes ribosome interaction with low GC 5’UTRs
To investigate the mechanism underlying the BUD23 dependent selection of transcripts we exam-
ined specific mRNA features associated with translational efficiency. Given the known influence of
5’UTR features on translation efficiency, we reasoned that specific features of the 5’UTR may be par-
ticularly important for BUD23 action. A number of well-characterised 5’UTR features impact mRNA
translation, including length, secondary structure, GC content, and specific motifs including the TOP
sequence (Gandin et al., 2016; Meijer and Thomas, 2002). We saw no enrichment for TOP
sequence content in the differentially translated mRNA species (Figure 1—figure supplement 2),
and no correlation between change in TE score and 5’UTR length was observed (Figure 1H). We
also noted that transcripts with shorter total lengths were not more likely to shift from the heavy to
the light fraction (Figure 1—figure supplement 3). There was, however, a highly significant correla-
tion between change in TE score and GC content (Pearson’s correlation value of  0.1337, p-val-
ue<2.2e 16) (Figure 1I). This identifies an intersection between mRNA transcript 5’UTR GC content
and BUD23 ribosome maturation. There was no difference in the distribution of 5’UTR GC in mito-
chondrial-related transcripts relative to all transcripts detected in the polysome analysis (Figure 1—
figure supplement 3).
Loss of BUD23 causes changes in cellular protein homeostasis
Our studies reveal the consequences for the ribosome of BUD23 action and point to an impact on
the cellular proteome. Therefore, to investigate the downstream consequences of BUD23 loss we
examined the cellular proteome by LC-MS/MS. BUD23 knockdown downregulated 83 proteins and
upregulated 64, out of a total of 3255 identified (Figure 2—source data 1). When tested using PAN-
THER GO cellular component ontology analysis, upregulated proteins were over-represented for
components of the large ribosomal subunit (14/64 proteins), whilst downregulated proteins were
Figure 1 continued
measured using SRB assay to indicate amount of proliferation. Polysome profiles were obtained from A549 cell lysates treated with (D) Control siRNA or
(E) BUD23 specific siRNA (si30) for 48 hr (n = 3). Changes in the ratio of the 40S peak to the 60/80S peak were observed between the two conditions.
Polysome fractions were divided into heavy (more than three ribosomes) or light (three or less ribosomes) before RNA sequencing.. A translational
efficiency (TE) score was derived by dividing the relative proportion of transcript abundance in the heavy fraction by that in the light fraction. (F) The TE
scores in the two conditions derived from the samples in A and B are plotted against each other. (G) Violin plot showing the change in translational
efficiency upon BUD23 siRNA treatment (‘change in TE score’) for all detected transcripts (All) versus mitochondrially-encoded transcripts
(Mitochondrial). (H) 5’UTR length of the transcripts was plotted against change in translational efficiency (TE, as defined in Figure 1G). The data are
plotted in bins with ‘change in TE’ (BUD23 TE/Control TE) windows of 0.5. (I) 5’UTR GC content was of the same transcripts was plotted against change
in TE. The data are plotted in bins with TE windows of 0.5.
The online version of this article includes the following figure supplement(s) for figure 1:
Figure supplement 1. Further analysis of BUD23-dependent ribosome function in A549 cells.
Figure supplement 2. 5’UTR motif analysis.
Figure supplement 3. Further analysis of polysome profile dataset.
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Figure 2. Proteomic analysis of BUD23 deficiency reveals mitochondrial phenotype Proteomics was performed on A549 cell lysates 48 hr after
transfection with either BUD23-targeting siRNA or control siRNA. Significantly down-regulated and up-regulated proteins were defined using Welch’s
T-test with a permutation-based FDR < 0.05. (A) Significantly down-regulated proteins were visualised as a network using String 10 online software. Red
nodes are 40S ribosomal proteins, Green nodes are mitochondrial proteins (B) Over-representation analysis of the significantly down-regulated protein
Figure 2 continued on next page
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over-represented for components of the small ribosomal subunit (22/83 proteins), (Figure 2A, Fig-
ure 2—figure supplement 1). This imbalance in the relative abundance of ribosomal proteins, reca-
pitulates the observation in the polysome profiles and confirms a major role for BUD23 in the
maturation of the protein translation apparatus of the cell. Interestingly, TRMT112 protein, an obli-
gate partner for BUD23, was also significantly down-regulated with BUD23 knock-down, which may
indicate a reciprocal stabilising interaction.
Ontology analysis of the proteomics dataset was used to predict the functional consequences of
BUD23 reduction (PANTHER GO biological processes). Over-representation analysis of the up-regu-
lated proteins overlapped significantly with the ‘protein translation’. Analysis of the down-regulated
proteins again showed a statistically significant over-representation for proteins associated with GO
biological terms including ‘translation’, as well as ‘rRNA metabolic process’ and ‘protein metabolic
process’ which support a major effect on the translational apparatus (Figure 2B). Unexpectedly,
there was also over-representation within the down-regulated proteins for the terms ‘Mitochondrion
organization’ and ‘Cellular component biogenesis’, suggesting a consequential impact on mitochon-
drial function, a major destination for new protein synthesis in the cell.
BUD23 regulates mitochondrial function
Because the TE of mitochondrial transcripts was down-regulated and mitochondrial organisation
emerged from the proteome analysis, specific assays of mitochondrial activity were performed.
Depletion of BUD23 with any of three, independent siRNAs resulted in a > 50% reduction in oxida-
tive phosphorylation (OXPHOS) and around a 25% reduction in Electron Transfer Capacity (ETC)
(Figure 2C,D,E) but no observable difference in leak respiration (LEAK), relative to control (Fig-
ure 2—figure supplement 2). Moreover, no alteration in glycolytic capacity was observed indicating
specificity for mitochondrial energetic pathways (Figure 2F). We also observed a reduction in mito-
chondrial mRNA abundance with BUD23 knockdown, but no change in mitochondrial genome copy
number, implying a functional defect, rather than loss of mitochondrial mass (Figure 2G,H,I),
although these measurements were performed soon after siRNA knockdown, and so a later impact
on mitochondrial mass resulting from prolonged BUD23 loss cannot be excluded.
To examine whether this mitochondrial transcription defect was specific to BUD23 deficiency, or
part of a more general mechanism resulting from 40S/60S imbalance, we performed siRNA-medi-
ated knockdowns of other known ribosome biogenesis factors, LTV1 and RIOK2, as well as the ribo-
somal small subunit protein RPS27A (also reported to result in ribosomal subunit imbalance)
(Sloan et al., 2019). Depletion of LTV1, RIOK2 and RPS27A all resulted in significant decrease in
18S/28S ratio relative to control siRNA, indicating a similar 40S/60S imbalance as observed with
BUD23 knockdown (Figure 2G, Figure 2—figure supplement 2). LTV1 knockdown resulted in a sim-
ilar decrease in mitochondrial transcript expression as observed in BUD23 knockdown (Figure 2H).
However, RPS27A and RIOK2 knockdown-induced ribosome imbalance did not affect mitochondrial
Figure 2 continued
dataset was performed using the PANTHER GO-Slim Biological Processes, and significantly over-represented terms were visualise using ggplot2. (C)
Mitochondrial stress test was conducted on A549 cells treated with BUD23-targeting or non-targeting control siRNA (n = 3). Oxygen consumption rate
(OCR) was measured over time to obtain mitochondrial respiration rates. Values for ETS (D) and OXPHOS (E) were derived from the OCR
measurements after the addition of oligomycin A (OA), FCCP and antimycin A + rotenone (AA+R) in succession. (F) Glycolytic capacity was tested using
a Seahorse glycolytic stress test and measuring extracellular acidification rate (ECAR). (G) A549 cells were treated with control siRNA (neg1) or siRNA
specifically targeting BUD23 (si30), RPS27A, LTV1 or RIOK2. 18S/28S ratio was measured using Tapestation to confirm ribosome subunit imbalance. (H)
MT-ND1 mRNA was measured by qPCR as an indicator of mitochondrial transcript abundance (relative to control gene HPRT). (I) Mitochondrial copy
number was measured relative to genomic copy number by qPCR. (J) Cellular fractionation into total ‘T’, cytosolic ‘C’, cellular debris ‘D’ and
mitochondrial ‘M’ fractions. Protein was isolated from these fractions before SDS-PAGE and immuno-blotting for BUD23 and TRMT112. POLRMT was
blotted as a control for mitochondrial proteins, TOM22 as a control for a mitochondrial membrane protein and GAPDH and Histone H4 as control non-
mitochondrial proteins.
The online version of this article includes the following source data and figure supplement(s) for figure 2:
Source data 1. Proteomics data table.
Figure supplement 1. Network analysis of up-regulated proteins.
Figure supplement 2. Further analysis of ribosomal deficiency in A549 cells.
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transcript expression (Figure 2H, Figure 2—figure supplement 2). This indicates that disruption of
40S subunit biogenesis is not by itself sufficient to result in mitochondrial dysfunction.
To check that BUD23 was not regulating mitochondria directly, we blotted for the protein after
sub-cellular fractionation. BUD23 was found to be abundant in the cytosolic fraction but was not
detected in the mitochondrial fraction after proteinase K digestion (Figure 2J). This suggests the
mechanism of BUD23 action does not occur within the mitochondria. Furthermore, TRMT112, the
obligate BUD23 binding partner, was also abundant in the cytosol, but barely detectable within
mitochondria (Figure 2J). Together these data indicate that BUD23-dependent mitochondrial regu-
lation is likely to be a downstream consequence of effects on ribosome composition, function, and
cellular protein repertoire, rather than a direct effect of BUD23 protein within the mitochondria.
Homozygous deletion of Bud23 results in embryo-lethality
To investigate the physiological impact of BUD23 we generated Bud23 null mice. We introduced a
frameshift deletion within the Bud23 gene, which resulted in a null allele (Figure 3A). However,
upon further breeding of heterozygous mice a clear deviation from the expected Mendelian ratio
was observed in the resultant offspring. Out of 74 pups born, 39 were found to be wild-type for the
Bud23 gene, 35 were heterozygous, and zero were homozygous for the null allele (Figure 3B), indi-
cating embryonic lethality in Bud23-null mice. This is in contrast to reports in yeast where BUD23
was shown to be non-essential for life (White et al., 2008). Furthermore, it is notable that approxi-
mately half the expected heterozygote birth rate was seen, implying an additional haplo-insufficiency
developmental death rate. Accordingly, we analysed embryos at day E10.5 and detected Mendelian
ratios of wild-type, and heterozygous animals, but again no homozygous null embryos were seen
(Figure 3B), suggesting total Bud23 loss is incompatible with embryogenesis, but haploinsufficiency
results in fetal death later in development.
Surprisingly, surviving adult heterozygous mice showed no difference compared to wildtype litter-
mate controls in body weight, lean body weight or body fat between 10 and 30 weeks of age
(Figure 3C). There was also no significant change in energy expenditure or respiratory exchange
ratio in Bud23+/- mice relative to WT littermate controls (Figure 3—figure supplement 1), suggest-
ing compensatory mechanisms to permit survival.
To circumvent embryonic lethality, we generated a floxed Bud23 allele mouse, allowing post-natal
tissue-specific KO (Figure 3A). Mice homozygous for this floxed Bud23 (Bud23fl/fl) allele showed no
observable differences from wild-type littermates. To confirm the embryonic lethality phenotype
using an independent genetic approach, we crossed these mice with a Cre-deleter mouse line (Hprt-
cre) (Nichol et al., 2011) to globally delete Bud23 alleles. Bud23+/- heterozygous crosses also failed
to generate any homozygous null offspring (0 out of 28 cre positive offspring), confirming the obser-
vation in the global knockout mouse line (Figure 3D).
We targeted Bud23 disruption to skeletal and cardiac muscle using Muscle Creatine Kinase
(Mck)-cre as the driver (Whitnall et al., 2008). Cardiac muscle relies heavily on mitochondrial pro-
duction of ATP in post-natal life, but less so during development, so offering us the chance to ana-
lyse BUD23 impact on a highly mitochondrially-dependent tissue. Bud23fl/fl Mck-Cre+/- mice
exhibited Cre-mediated deletion of exon 7 of the Bud23 gene in cardiac tissue, with a consequent
reduction in BUD23 protein levels (Figure 3E,F).
BUD23 deficiency drives preferential dysregulation of mitochondrial
proteins
Loss of BUD23 in cardiac muscle resulted in sudden death between the age of 28–35 days
(Figure 4A). Littermate control mice expressing Bud23fl/flMck-Cre-/- or Bud23fl/wt Mck-Cre+/- (i.e.
mice retaining at least one functional copy of the Bud23 allele) were viable, fertile and did not die
prematurely (Figure 4A). Mouse tissues from this line were therefore subsequently harvested at 26
days of age. A significant reduction in the 18S/28S RNA ratio, consistent with the in vitro data using
siRNA knockdown was observed at this time point (Figure 4B).
Proteomic analysis of cardiac tissue recovered from 26 day old Bud23fl/flMck-Cre+/- mice and lit-
termate controls (Bud23fl/flMck-Cre-/-) revealed a significant decrease in protein content per cell with
loss of BUD23 (Figure 4C), with clear separation by genotype (Figure 4—figure supplement 1).
When detected proteins were annotated by sub-cellular compartment, mitochondria were found to
Baxter et al. eLife 2020;9:e50705. DOI: https://doi.org/10.7554/eLife.50705 8 of 26
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Figure 3. Generation and characterisation of murine Bud23 null and floxed alleles. (A) Schematic of the targeting strategy used to create a murine
Bud23 knockout allele and a floxed allele were generated by CRISPR-Cas9. (B) Genotype analysis of day E10.5 embryos and the offspring from
heterozygous breeding pairs. (C) Bud23 Heterozygous (HZ) and wildtype (WT) mice (10–30 weeks old) were analysed over time for body composition by
ECHO-MRI. (D) Genotype analysis of offspring from heterozygous recombined Bud23 (Bud23rec/wt) allele crosses. (E) PCR amplification of the Bud23
genomic locus in Bud23fl/fl mice positive or negative for MCKcre expression in heart tissue, shows successful recombination of the mutant Bud23 allele
(bp = base pairs). (F) Disruption of BUD23 protein in the cre positive animals was confirmed by Western blot.
The online version of this article includes the following figure supplement(s) for figure 3:
Figure supplement 1. Metabolic analysis of BUD23 heterozygous mice.
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compared to littermate controls (Bud23wt/fl Mck-Cre-/-, Bud23wt/fl Mck-Cre+/-, Bud23fl/fl Mck-Cre-/-), all shown in red. For subsequent analyses, hearts
were collected from 26 day old Bud23fl/fl Mck-Cre+/-, and Bud23fl/fl Mck-Cre-/- littermate controls. (B) 18S/28S ratio analysis of RNA extracted from
Figure 4 continued on next page
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be subject to the largest loss of protein content, with small reciprocal increases in the other com-
partments (Figure 4D), again identifying mitochondria as especially sensitive to BUD23 action. Of
the 2047 proteins identified by mass spectroscopy, 347 were found to be significantly up-regulated
and 442 were found to be significantly down-regulated in the BUD23 deficient condition (Figure 4E,
Figure 4—source data 1). Whilst an approximately equivalent number of down and up regulated
proteins was identified globally, when this list was refined to mitochondrial proteins only 20 were
up-regulated compared to 220 down-regulated (50% of all down-regulated proteins) (Figure 4F). By
contrast, the up-regulated dataset was enriched for translational (60S proteins) and proteasomal
proteins (Figure 4—figure supplement 1). Whilst correlation between change in protein abundance
in BUD23-deficient heart tissue and change in mRNA TE of the corresponding transcripts in the
BUD23 siRNA treated A549 cells was poor overall (Figure 4—figure supplement 2), it is striking
that mitochondria are affected to a great extent in both models. These observations show a strong
selectivity for impaired expression of mitochondrial proteins as a result of BUD23 deficiency.
Within the set of mitochondrial proteins, we found that electron transport chain complexes I, IV
and V (ATP synthase) were most strongly reduced in response to loss of BUD23 (Figure 4—figure
supplement 3). Furthermore, ontology analysis of all the significantly down-regulated proteins iden-
tified three main clusters of proteins: mitochondrial proteins, mitochondrial ribosomal proteins and
proteins involved in energy metabolism, indicating a functional mechanism linking between the
BUD23 dependent ribosomal defect, through reduced mitochondrial protein expression to result in
disruption of energy metabolic pathways (Figure 4G). Therefore, BUD23 actions on the ribosome
result in down-regulation of core mitochondrial proteins involved in ATP synthesis.
BUD23 deficiency causes mitochondrial dysfunction in cardiomyocytes
Given the observation of preferential dysregulation of mitochondrial proteins, we hypothesised that
mitochondrial function was likely to be compromised in BUD23-deficient cardiac tissue. Mitochon-
drial DNA copy number was reduced in BUD23 deficient cardiac tissue (Figure 5A). Functional analy-
sis of mitochondrial function in cardiac homogenates using the Oroboros microrespirometer system
revealed that mitochondrial OXPHOS and ETC were both significantly reduced in mice deficient for
BUD23, while LEAK respiration was unaffected (Figure 5B). The reduction in OXPHOS led to a lower
respiratory control ratio (RCR) indicating that mitochondria from mice deficient for BUD23 were less
efficient at producing ATP. These effects were apparent regardless of which substrate was used for
electron donation. In addition to reduced mitochondrial capacity, mice deficient for BUD23 had
lower citrate synthase activity, indicating a reduction in cardiac mitochondrial density (Figure 5C),
which accords with the measured loss of mitochondrial genome copy number (Figure 5A).
To test whether haplo-insufficiency of BUD23 protein was enough to impair mitochondrial func-
tion we also tested heart homogenates from Bud23+/- mice. These were found to have no significant
difference in mitochondrial respiratory capacity across any mitochondrial state (LEAK, OXPHOS,
ETS), whether normalised to citrate synthase activity or protein content (Figure 5—figure supple-
ment 1). It was, however, noted that, compared to wild-types, Bud23+/- mice did exhibit significantly
higher citrate synthase activities, indicating greater mitochondrial density. This may result from
increased mitochondrial biogenesis to compensate for defective oxidative phosphorylation function
and may partly explain the reduced viability in Bud23+/- mice. Interestingly, the impact of BUD23
Figure 4 continued
BUD23 positive or negative mouse hearts using TapeStation. (C) Proteomics was performed on heart tissue from Cre +ve and Cre -ve littermates
(n = 3). Total protein concentration per cell is shown, as determined via the proteomic ruler approach. (D) Relative contribution levels of each organelle
to total protein mass based on ontology. The decrease in mitochondrial mass observed in Cre positive hearts is indicated. (E and F) Volcano plots of
either total protein or mitochondrial protein fold change differences in Cre positive hearts relative to Cre negative hearts. Significantly up- and down-
regulated proteins are indicated in red (FDR < 0.05, s0 = 0.2). (G) Functional enrichment network of total down-regulated proteins. The network was
built using String 10 online software prior to export into Cytoscape.
The online version of this article includes the following source data and figure supplement(s) for figure 4:
Source data 1. Proteomics data table.
Figure supplement 1. Proteomic analysis of BUD23 deficient mouse hearts.
Figure supplement 2. Change in TE correlates poorly with change in protein abundance.
Figure supplement 3. Network analysis of down-regulated proteins in BUD23 deficient mouse hearts.
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Figure 5. Analysis of mitochondrial structure and function in BUD23 depleted heart. Mouse tissues were collected at 26 days old. (A) Mitochondrial
genome copy number measured in the heart tissue by qPCR, relative to autosomal genome copy number (n = 6). (B) Mitochondrial respiration was
measured in heart homogenates (n = 5–6). Oxygen consumption was measured under various mitochondrial states and normalised to protein content:
LEAK conditions (malate, pyruvate and glutamate as substrates); OXPHOS (routine respiration rate) through Complex I, I+II or IV; ETC (maximal
Figure 5 continued on next page
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loss on mitochondrial function appears to be sexually-dimorphic. When mitochondrial respiration
was normalised to citrate synthase, male heterozygous (HZ) mice exhibited a deficiency in OXPHOS
and ETS relative to wildtype, whereas female mice did not (Figure 5—figure supplement 1). This
observation indicates a more severe phenotype in BUD23 deficient males, with further derangement
of individual components of the electron transport chain.
Analysis of mitochondrial morphology, and operation of compensatory
circuits in targeted cardiac muscle
Electron microscopy (EM) analysis revealed that despite decreased mitochondrial protein abundance
and reduced mitochondrial function in the BUD23 cardiac tissue, the individual mitochondria appear
to be formed normally with an equivalent number of cristae compared to the wildtype. The inter-
myofibrillar mitochondria were typically arranged in a highly ordered pattern in the wildtype cardiac
tissue, however, there was marked disorganisation in the BUD23-deficient cardiac tissue
(Figure 5D). In addition, we identified the presence of numerous spherical electron dense inclusion
bodies within the mitochondria of BUD23 deficient cardiac cells (Figure 5D, yellow arrows). Similar
electron dense structures have been previously reported in myocardial mitochondria, which may
accumulate in response to increased cellular bioenergetic demand (Jacob et al., 1994). The obser-
vation of these structures here may be consistent with attempted mitochondrial adaptation to ener-
getic-demand challenge.
A frequent cellular adaptation to impaired oxidative phosphorylation is a switch to glycolytic ATP
generation, and so we measured rate-limiting glycolytic gene expression (Figure 5E). We identified
a significant induction of glucokinase (GCK), and a trend to induction of phosphofructokinase (PKM)
and hexokinase (HK2) supporting such an adaptive switch to glycolysis. A further adaptation pre-
dicted was an induction in mitochondrial biogenesis programmes. We identified a significant induc-
tion in PGC1a and PGC1b, but no change in TFAM1 expression (Figure 5E). Taken together these
results point to some of the expected cellular responses to loss of oxidative phosphorylation, but it
was surprising that the changes were so few. This implies that additional cellular injury may be pro-
ceeding, which acts to limit successful adaptation.
Impaired mitochondrial function may result in overproduction of reactive oxygen species, which
can trigger the apoptotic cascade and lead to cell death. Such a progression may explain the dis-
torted and thinned ventricular walls observed in the cardiac Bud23-null mice. We found induction of
NRF2 (Figure 5E), a key sentinel gene controlling cellular responses to reactive oxygen species
stress, which led us to measure reactive oxygen species directly, and found that these were signifi-
cantly higher in hearts lacking BUD23 expression (Figure 5F), identifying a burden of increased reac-
tive oxygen species in BUD23 deficient cardiomyocytes resulting from the action of deranged
mitochondria.
BUD23 deficiency in cardiac muscle leads to dilated cardiomyopathy
Deficient mitochondrial generation of ATP in cardiac tissue is a key cause of cardiomyopathy. Given
the strong mitochondrial deficiencies observed in BUD23-deficient cardiac tissue, we predicted that
the cardiomyopathy was the likely cause of sudden death. Histological examination of hearts from
Bud23fl/fl Mck-Cre+/- (BUD23-deficient) mice showed significant enlargement, ventricle dilatation and
decreased ventricle wall thickness compared to littermate controls at 26 days old (Figure 6A–D).
Figure 5 continued
respiration rate) through Complex I+II and II; Respiratory Control Ratio (RCR, measure of mitochondrial efficiency). (C) Citrate Synthase activity was
measured in the heart homogenates as a marker of mitochondrial content. (D) Electron microscopy images of mitochondria in cardiomyocytes from
either Bud23fl/fl (WT) hearts, or Bud23fl/fl Mck-Cre +ve (KO) hearts. Accumulation of electron dense granules is visible in Bud23fl/fl Mck-Cre +ve (KO)
hearts, denoted by arrows. (E) These hearts were further analysed for expression of mitochondrial biogenesis genes, markers of glycolysis,
mitochondrial biogenesis, oxidative stress and indicators of mitochondrial transcription using qPCR. (F) ROS was measured simultaneously with O2
consumption (see Figures 1–3) under various mitochondrial states and normalised to citrate synthase activity: LEAK conditions (malate, pyruvate and
glutamate as substrates); OXPHOS (routine respiration rate) through Complex I or I+II; ETS (maximal respiration rate) through Complex I+II and II, and
in the presence of antimycin-A (residual oxygen consumption, ROX)(n = 5–6).
The online version of this article includes the following figure supplement(s) for figure 5:
Figure supplement 1. Oroboros analysis of mitochondrial function in cardiac homogenates from HZ mice and WT littermate controls.
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Figure 6. Targeted disruption of Bud23 in cardiac tissue results in dilated cardiomyopathy. (A) Heart sections cut in the coronal plane and stained with
haematoxylin and eosin from day 26 mice. Representative images are shown. (B) Heart weight measured as a ratio to total bodyweight. (C and D)
Analysis of heart ventricle wall thickness in H and E stained heart sections. (E) Echocardiography of Bud23fl/flMck-Cre+/- mice and littermate controls at
26–28 days of age (n = 9–10). Mice were lightly anesthetized maintaining the heart rate at approximately 450 beats/min. Data for diastolic diameter
(dD), systolic diameter (sD), fractional shortening (FS) and relative wall thickness (RWT) are shown; full parameter measurements are shown in
supplementary. (F) Electrocardiography of Bud23fl/flMck-Cre+/- mice and littermate controls at 26–28 days of age (n = 9–10). Data for QRS, QTc and JT
intervals are shown. Full parameter measurements are shown in supplementary. * denotes statistical significance (p<0.05) using Student’s T-test.
The online version of this article includes the following source data and figure supplement(s) for figure 6:
Source data 1. Data table of echocardiogram analysis results and electrocardiogram analysis results.
Figure supplement 1. Fibrosis markers are up-regulated in BUD23 deficient mouse hearts.
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Littermate control mice expressing Bud23fl/flMck-Cre-/- or Bud23fl/wt Mck-Cre+/- (i.e. mice retaining
at least one functional copy of the Bud23 allele) were viable, fertile and did not die prematurely
(Figure 3A).
Echocardiogram analysis of Bud23fl/fl Mck-Cre+/-mice at 26–28 days old showed that cardiac
BUD23-deficiency resulted in systolic dysfunction indicated by significantly dilated left ventricle (sD),
as well as significantly decreased fractional shortening and relative wall thickness (Figure 6E, Fig-
ure 6—source data 1).). There was, however, no observed pulmonary oedema or liver oedema (Fig-
ure 6—figure supplement 1,). Further analysis of the heart proteomics data from Figure 4 showed
an increase in a number of markers of fibrosis, including Col4a2, CTGF, Galectin-3 and others (Fig-
ure 6—figure supplement 1). Taken together, these observations indicate that Bud23fl/fl Mck-Cre+/-
mice exhibit the early stages of heart failure around 26–28 days of age. Electrocardiogram analysis
of the same mice at the same age revealed significantly shorter QRS and corrected QT (QTc) inter-
vals but no change in heart rate (Figure 6F; Figure 6—source data 1).).
Discussion
BUD23 is tightly conserved through evolution and has recently emerged as a ribosomal RNA methyl-
transferase, although its physiological role in mammals is unexplored. It is one of the genes deleted
in Williams-Beuren Syndrome, a complex multi-gene deletion syndrome with neurological, and
energy homeostatic features, although themediating role of individual genes to the phenotype has
not been determined (Morris, 1993). We now identify BUD23 as playing a major role in regulating
the translational efficiency of specific transcripts through its role in ribosome maturation. Indeed,
translation of low 5’UTR GC-content mRNA species were particularly dependent on BUD23 expres-
sion, in contrast to the picture seen with simple ribosome deficiency in which transcripts with short/
unstructured 5’UTRs were seen to be most affected (Khajuria et al., 2018). Furthermore, we identi-
fied a surprising role for BUD23 in maintaining mitochondrial oxidative phosphorylation capacity. As
protein translation is tightly coupled to ATP demand this raised the possibility that BUD23-depen-
dent ribosomal maturation is critical to link the two processes in living cells and tissues
(Morita et al., 2013). Indeed, BUD23 loss greatly impaired mitochondrial ATP generation, both in
vitro and in vivo. In mice, cardiomyocyte loss of BUD23 greatly impaired mitochondrial ATP genera-
tion leading to dilated cardiomyopathy and premature death, and global loss of BUD23 resulted in
embryo-lethality.
BUD23 is thought to perform two functions in the generation of the translational apparatus:
firstly, in the processing of pre-18S RNA into its mature form, and secondly imparting a m7-G methyl
mark on a key residue. As the catalytic activity of BUD23 is not required for efficient pre-18S RNA
processing, these two functions appear to be independent of each other (Haag et al., 2015;
Zorbas et al., 2015). It is notable that both the BUD23 imparted m7-G methyl mark and structurally
complex 5’UTRs are characteristic features of translation specific to Eukaryotes. We speculate the
co-evolution of this regulatory 18S methyl mark with the need for more complex regulation of differ-
ential translation. Further work should focus on delineating the effect of BUD23-dependent 18S mat-
uration, from the role of the methylation mark.
We used proteomics to examine the relative changes in protein abundance which result from tar-
geted loss of BUD23 in cardiomyocytes. This revealed a selective loss of mitochondrial proteins,
explaining the observed reduction in mitochondrial capacity. As BUD23 appears to have no direct
role within mitochondria we propose that the mitochondrial phenotype results from impaired trans-
lation of nuclear-encoded genes with a role in mitochondrial homeostasis. Indeed, we found that the
translational efficiency of a number of mitochondria-targeted as well as mitochondrial regulating
proteins were BUD23-dependent. There are many potential candidates linking the change of transla-
tional efficiency to the mitochondrial phenotype. Mammalian target of rapamycin (mTOR), for exam-
ple, is known to regulate mitochondrial activity and biogenesis by regulation of translation
(Morita et al., 2013) and, interestingly, BUD23 loss resulted in impaired translation of mTOR itself.
We also observed a marked decrease in the translational efficiency of mitochondrially-encoded
transcripts.
We initially generated and characterised a frame shift-generating null allele mouse. The homozy-
gote null animals were all lost prior to embryonic day e10.5 and we were unable to identify a cause
but considered that a major defect in a mitochondrially–dependent organ such as heart may be a
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plausible mechanism. We moved, therefore, to a conditional allele mouse, using which we confirmed
the developmental lethality of the null allele by crossing with a global deleter-cre strain (Hprt-cre).
Using the conditional allele mice with a muscle Cre driver we were able to profile the impact of
BUD23 in a physiological role. Loss of BUD23 in heart and skeletal muscle resulted in early death
from cardiac failure. This striking phenotype was accompanied by morphological changes including
cardiac dilatation, ventricular wall thinning, and impaired ventricular contractility. There was evidence
for an attempted switch to glycolytic ATP generation in the hearts, with induction of rate-limiting
glycolytic enzyme genes; and also adaptation to conditions of oxidative stress with induction of
NRF2. Mitochondrial dysfunction frequently imposes a burden of oxidative stress on affected cells,
which can result in apoptosis, thereby explaining the loss of cardiac muscle seen. Detailed ultrastruc-
ture analysis of cardiac mitochondria revealed no major loss of mitochondrial volume, but there was
a striking additional feature seen within the mitochondria: electron-dense, spheroid inclusions. These
were not observed in control hearts, and are not typically seen in mitochondria from individuals with
mitochondrial myopathies, but have been reported before under conditions of extreme ATP
demand, and to result from bilayer budding from the inner cristae, to generate additional ATP gen-
erating surface area (Jacob et al., 1994; Somlyo et al., 1974). Therefore, we propose this may be a
further adaptation to the impaired oxidative phosphorylation function within the mitochondria.
There is a growing recognition that transcriptional control mechanisms are insufficient to explain
differentiated cell function. Recent advances have identified differential translation of mRNA species
dependent on 5’UTR features as an important control mechanism, potentially coupling global
changes in protein translation with appropriate upregulation of mitochondrial ATP generation to
meet demand 2. BUD23, a highly conserved ribosomal RNA methyltransferase which lies within a
multigene interval, deleted as a cause of Williams-Beuren syndrome, plays a specific role in highly
ATP-hungry cells, promoting translation of mitochondrial proteins, and impacting on oxidative phos-
phorylation. This function likely contributes to aspects of the human phenotype, in particular neuro-
logical dysfunction, glucose intolerance and obesity. Complete global loss of Bud23 is embryonic
lethal, and early post-natal death follows deletion of Bud23 in the heart. The cardiac phenotype is
severe, with marked mitochondrial dysfunction, and evidence of compensatory changes towards gly-
colytic ATP generation, and adaptation to oxidative stress. Therefore, BUD23 plays a critical role in
coupling protein translation to mitochondrial function, with implications for mitochondrial diseases,
and cardiomyopathies.
Materials and methods
Key resources table
Reagent type
(species) or resource Designation Source or reference Identifiers
Additional
information
Gene (Homo sapiens) BUD23 Gene ID: 114049 Aliases:
WBSCR22, MERM1
Genetic reagent
(Mus musculus)
Bud23null This paper Bud23null Mutant allele: deleted exon
7 of BUD23 gene
Genetic reagent
(Mus musculus)
BUD23fl/fl This paper BUD23fl/fl Mutant allele: floxed exon
7 of BUD23 gene
Genetic reagent
(Mus musculus)
Mck-Cre Whitnall et al., 2008 B6.FVB(129S4)-Tg
(Ckmm-cre)5Khn/J
Heart and muscle
specific Cre-driver
Cell line
(Homo-sapiens)
A549 ATCC CCL-185 Airway epithelial
adenocarcinoma
Antibody anti-BUD23
(Rabbit polyclonal)
GeneTex Cat# GTX105840 WB (1:500)
Sequence-
based reagent
BUD23_F This paper Genotyping primers 5’-CCTGGCTGATGTGTTGCTTT-3’
Annealing temperature: 62˚C
Sequenced-
based reagent
BUD23_R This paper Genotyping primers 5’-GCTGCACATCTCTCCTCACT-3’
Annealing temperature: 62˚C
Sequence-
based reagent
MT-ND1_F This paper qPCR primers 5’-GAAGTCACCCTAGCCATCATTC-3’
Continued on next page
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Continued
Reagent type
(species) or resource Designation Source or reference Identifiers
Additional
information
Sequenced-
based reagent
MT-ND1_R This paper qPCR primers 5’GCAGGAGTAATCAGAGGTGTTC-3’
Sequenced-
based reagent
siRNA: nontargeting
control 1
Thermo Fisher AM4611 Silencer Select
Sequenced-
based reagent
siRNA: nontargeting
control 2
Thermo Fisher 4390847 Silencer Select
Sequenced-
based reagent
siRNA:
BUD23
Thermo Fisher 41529 Silencer Select
Sequenced-
based reagent
siRNA: BUD23 Thermo Fisher 41530 Silencer Select
Sequenced-
based reagent
siRNA: BUD23 Thermo Fisher 41531 Silencer Select
Software,
algorithm
R www.r-project.org Key packages:
-EDGER
-BIOCONDUCTOR
-EDASEQ
Commercial
assay or kit
Seahorse XF
Mito stress test
Agilent 103015–100
Commercial
assay or kit
Seahorse XF
Glyco stress test
Agilent 103020–100
Animals
All mice were routinely housed in 12:12 light/dark (L:D) cycles with ad libitum access to food and
water. All experiments were carried out in accordance with the Animals (Scientific Procedures) Act
1986 (UK) under Home Office protocol number 70/8768 and P3A97F3D1. In studies utilizing condi-
tional targeted mice, littermate controls (floxed/floxed) were used as control; these mice carried no
copies of the Cre or iCre. Genotyping was performed on all experimental animals.
Physiological monitoring
To assess body composition, whole body, fat mass and lean body mass was assessed using the
EchoMRI system (Echo Medical Systems). To assess metabolic gas exchange, mice were individually
housed in indirect calorimetry cages (CLAMS, Columbus Instruments). Mice were acclimatised to the
cages for 48 hr prior to recording data. Measurements of O2 consumption and CO2 production were
recorded every 10 min for >72 hr. RER was derived from these measures (VCO2/VO2), as was energy
expenditure (3.815*VO2 + 1.232
*VCO2).
Generation of Bud23 conditional KO mice
In order to conditionally KO the Bud23 gene by Cre recombinase expression we generated a trans-
genic mouse line with the critical exon seven flanked by LoxP sites. Exon seven has an unequal splic-
ing phase, meaning its Cre mediated excision would lead to a frame shift and KO of the Bud23
gene. This exon is also flanked by large introns giving sufficient space to insert LoxP sites without
perturbing normal gene splicing and regulation. We used CRISPR (clustered regularly interspaced
short palindromic repeats)-Cas9 in the mouse zygote to integrate these LoxP sites.
Briefly, sgRNA targeting this genomic region, and with minimal off target potential, were identi-
fied (sgRNA-1 GGCATTGGGCCTACTTAAAG-GGG, sgRNA-2 AGTTGAAGGGTTCCATAATG-AGG,
sgRNA-3 CTTTACAGCCCAAGACCACT-TGG) and selected for use. sgRNA was synthesised in vitro,
using protocols developed by Bassett et al. (2013). Forward primers of the form GAAATTAATAC-
GACTCACTATA GGN18-20GTTTTAGAGCTAGAAATAGC (where GGN18-20 is the sgRNA sequence)
for each guide were combined with the universal reverse primer, AAAAGCACCGACTCGGTGCCAC
TTTTTCAAGTTGATAACGGACTAGCCTTATTTTAACTTGCTATTTCTAGCTCTAAAAC and used in a
PCR reaction with high fidelity polymerase (Phusion, NEB). 200 ng of the resulting amplicon were
used overnight in an in vitro transcription reaction (HiScribe, NEB, as per manufacturer’s instruc-
tions), before purification (Megaclear, Ambion) and quantification by nanodrop.
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A double stranded DNA (dsDNA) repair template was designed to (i) incorporate loxP sites, with
unique restriction sites for screening purposes, 300 bp upstream and 200 bp downstream of exon
seven respectively and (ii) integrate silent shield mutations for all three sgRNA to prevent cutting of
the repair template and (iii) contain 1000 bp 5’ and 3’ homology arms to the target region. The
above template was synthesised in a pUC57 vector (Genscript, US), the linear 5’homology-loxP-
exon7-loxP-3’homology fragment excised from the vector by restriction digest, gel extracted (Biol-
ine) and further cleaned prior to microinjection (Monarch PCR purification kit, NEB).
An injection mix of the three sgRNA (40 ng/ul each), Cas9 mRNA (100 ng/ul) and the dsDNA
repair template (10 ng/ul) was prepared and directly microinjected into B6D2F1 (Envigo) zygote pro-
nuclei using standard protocols. Zygotes were cultured overnight and the resulting 2 cell embryos
surgically implanted into the oviduct of day 0.5 post-coitum pseudopregnant mice.
Potential founder mice were screened by PCR and digest. Animals positive for both 5’ and 3’
LoxP integration had the region fully verified by pCR-Blunt cloning followed by Sanger sequencing.
two founder mice were identified and then back-crossed to C57BL/6J wild-type mice to assess
germline penetrance. Additionally, the described CRISPR targeting strategy resulted in deletion of
critical exon 7, a global Bud23 KO line was generated from this founder animal.
Genotyping
DNA was extracted from ear snip or tail tip using REDExtract-N-Amp tissue PCR kit (Sigma). Primer
sequences and PCR reaction conditions are listed in the key resources table and the primer sequen-
ces supplementary file. PCR products were resolved on 1.5% agarose gels.
Cells
STR authenticated A549 cells were obtained from the European Collection of Cell Cultures (ECACC
Cat no: 86012804) and maintained in culture, incubated at 37˚C in humidified air, 5% v/v CO2. Cul-
tured cells were tested regularly for mycoplasma contamination. A549 cells were cultured in DMEM
growth medium (Sigma, D6546), supplemented with 2 mM L-Glutamine (Sigma, G7513), 10% foetal
calf serum (FCS) (Sigma, F96665).
Depletion of BUD23 with siRNA
A549 cells were plated at 1  10^6 cells in a 10 cm cell culture dish and transfected with BUD23 spe-
cific or non-targeting control siRNA (S41529, S41530, S41531, negative control 1, negative control
2, Ambion Silencer Select) using Dharmafect DF-1 according to the manufacturer’s guidelines.
Mass spectrometry
A549 cell pellets were lysed in M-PER mammalian protein extraction reagent (Thermo Scientific).
Whole mouse hearts were dissected, quartered and washed in ice cold PBS to remove blood before
disruption of the tissue in 1x TBS supplemented with protease inhibitor cocktail using a TissueRuptor
(Qiagen). SDS was added to a final concentration of 4% (w/v) prior to sonication. Samples were then
reduced with 100 mM DTT and heated for 3 min at 95˚C. Samples were prepared for label-free
quantification in accordance with published protocols (Hernandez-Valladares et al., 2016).
Digested samples were analysed by LC-MS/MS using an UltiMate 3000 Rapid Separation LC (RSLC,
Dionex Corporation, Sunnyvale, CA) coupled to a Q Exactive HF (Thermo Fisher Scientific, Waltham,
MA) mass spectrometer using a stepped normalized collision energy centered at 28.
A549 peptide mixtures were separated using a multistep gradient from 95% A (0.1% FA in water)
and 5% B (0.1% FA in acetonitrile) to 7% B at 1 min, 18% B at 58 min, 27% B in 72 min and 60% B at
74 min at 300 nL min 1, using a 75 mm x 250 mm i.d. 1.7 mM CSH M-Class C18, analytical column
(Waters), for a final run time of 90 min. Cardiac samples were separated using a gradient from 5% B
to 7% B at 1 min, 18% B at 81.5 min, 27% B at 102 min and 60% B at 104 min, with a final run time
of 120 min. The top 12 precursors were selected for fragmentation automatically by data dependant
analysis during each cycle.
Ionization potential was set at 1900V with a survey scan window of 300–1750 m/z. MS1 used a
resolution of 120,000 with a target ion intensity of 3e6. Higher-energy collisional dissociation was
used. MS2 was set at a resolution of 60,000 with a target ion intensity of 2e5. Maximum injection
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times for MS1 and MS2 were 20 ms and 110 ms respectively. Peptides were dynamically excluded
for 15 s after one occurrence.
Mass spectrometry data analysis
Mass spectra were analysed using MaxQuant version 1.6.0.16 (Cox and Mann, 2008), searching
against either the Uniprot Mus musculus database (accessed 21/12/2017) or Homo sapiens database
(accessed 12/03/2017) using the native Andromeda search engine. Match between runs was
selected with a retention time of 1 min, using default parameters for all other settings. MS1 search
tolerance was set at 20ppm, and MS2 at 4.5ppm. Modifications were set as Carbamidomethyl (C)
for fixed, and Oxidation (M) and Acetyl (Protein N-term) variable. A minimum of 1 spectra was
required for identification, while a minimum of 2 spectra were required for quantification. Resulting
data was processed using Perseus version 1.6.0.7 (Tyanova et al., 2016) and R statistical software
(Wickham, 2009; R Development Core Team, 2017). All proteins identified by site only, as a poten-
tial contaminant, or in the decoy reverse database were excluded. Data was then filtered to exclude
proteins with more than 3 ‘zero-values’ across all groups. All proteins assigned to the GO term
‘blood microparticle’ were removed as well. LFQ values were log(2) transformed and missing values
imputated in Perseus using a normal distribution (Lazar et al., 2016). The width of the new distribu-
tion was 0.3 standard deviations of the data, and was shifted downwards by 1.8 standard deviations
of the data. A total of 6.68% of values were imputated. Significance was determined using a T-test
with a permutation based FDR (FDR < 0.05, s0 = 0.1). s0 represents the relative importance of the
difference between the means, with non-zero s0 values taking fold change, and not only p-value,
into account. Estimations of copy numbers were performed using the proteomic ruler plug-in version
0.1.6 (Wis´niewski et al., 2014). Proteins were then mapped to subcellular localisations to determine
percentage protein mass by organelle according to published protocols using the HeLa spatial pro-
teome database (Doll et al., 2017; Itzhak et al., 2016). Interaction networks were built using String
10 online software (Szklarczyk et al., 2017) using seven data sources (textmining, experiments,
databases, co-expression, neighborhood, gene fusion co-occurrence) and imported into
Cytoscape (Shannon et al., 2003). Network edges represent confidence. A minimum interaction
score of 0.4 (medium confidence) was required for network inclusion. Enrichment analysis was per-
formed using PANTHER (Mi et al., 2017). Lists of proteins were exported for the identified GO
terms and then manually coloured using Cytoscape for visualization.
Echocardiogram
Transthoracic echocardiography (TTE) was performed using a Vevo 770 High-Resolution Imaging
System (Visualsonics Inc, Toronto, Canada) and a 30MHz probe. Mice were lightly anesthetized with
1–1.5% isoflurane via facemask, maintaining the heart rate at approximately 450 beats/min. Views
were taken in planes that approximated the parasternal short-axis view and the apical long-axis
view. M-mode tracings were used to determine left ventricular end-diastolic diameter (LVDD) and
end-systolic diameter (LVSD), posterior wall thickness in diastole (LVPWD) and systole (LVPWS), and
interventricular septum thickness in diastole (IVSD) and systole (IVSS) over three cardiac cycles. The
analysis was performed blinded to animal details. LV fractional shortening (FS) was calculated using
the formula FS = [(LVDD - LVSD)/(LVDD)] x 100. Relative wall thickness (RWT) was calculated using
the equation RWT = (IVDD + LVPWD)/LVDD.
Electrocardiogram (ECG)
Mice were lightly anesthetized with 1–1.5% isoflurane via facemask. The body temperature was
maintained around 37˚C using a heat pad. The lead II ECG was recorded using Power Lab/4SP sys-
tem (Adinstruments) from needle electrodes inserted subcutaneously into the left and right forelimbs
and the right hindlimb. The signal was acquired for about 5 min using Chart 7 software (Adinstru-
ments). During offline analysis, the 5 min recording was examined for unusually shaped P, QRS, or
‘T’ waves and for time-varying phenomenon (e.g. irregularities in interval durations). Ectopic or
abnormal beats are noted. A representative 10–15 s segment of the recording was averaged to
obtain the signal averaged ECG to calculate Heart rate, RR interval, P wave duration, PR interval,
QRS, JT and QT durations. QT duration was corrected (QTc) using the Bazett’s formula
(Bazett, 1997).
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Polysome profiling
Polysome profiles were prepared according to the protocols previously published in: (Gandin et al.,
2014). Two conditions were profiled, BUD23 siRNA and Control siRNA, with an n of 3 samples per
condition. Fractions were collected from each sample and RNA was purified using the Trizol extrac-
tion method. RNA from fractions containing three or less ribosomes were pooled (‘Low translational
efficiency) and RNA from fractions containing more than three ribosomes (‘high efficiency’) were
pooled. Sub-polysomal fractions were similarly pooled. RNA sequencing was used to quantify the
expression of RNA species in each of the pooled samples. Translational efficiency (TE) was defined
as the relative abundance of a transcript in the high and low efficiency pooled fractions. A TE score
for each transcript was calculated by averaging the ratio derived from each of the three replicates in
each condition. TE was plotted for the two conditions using R software.
Translational efficiency (TE) was then compared to both the length and GC content of the 5’ UTR
region. 5’ UTRs were defined using the TxDb.Hsapiens.UCSC.hg38.knownGene (Bioconductor Core
Team and Bioconductor Package Maintainer, 2016) and org.Hs.eg.db (Carlson, 2018) R packages.
Sequences of the regions were extracted using the twoBitToFa program from the BLAT suite
(Kent, 2002) and then GC content was calculated using the seqinr R package (Charif and Lobry,
2007). The Pearson correlation coefficients, and their relative significances, were calculated using
cor.test function from the stats R package (R Development Core Team, 2017).
Assessment of mitochondrial function using seahorse
Live cell metabolic assays were performed on A549 cells pre-treated with either BUD23 siRNA or
control siRNA using a Seahorse XFe 96 analyser (Agilent). Mitochondrial stress tests was performed
according to the manufacturer’s instructions (Agilent). 2M Oligomycin (OA), 1M FCCP and 0.5M
rotenone/antimycin A (AA+R) were used for all conditions. A549 cells were plated into Seahorse
XF96 plates at 160,000 cells per well, utilising 16 wells per condition. Cell density was normalised
using SRB assay. Experiments were performed in triplicate.
Assessment of mitochondrial function using oroboros
Of the three distinct experimental preparations available (isolated mitochondria, permeabilized
fibers, and tissue homogenates), we utilized cardiac homogenates for mitochondrial assessment (see
Goo et al., 2013 for advantages of this method). Ventricular tissue (~20 mg) was weighed and trans-
ferred to 1.5 ml of ice-cold MiRO5 medium (in mM: EGTA 0.5, MgCl2 1.4, taurine 20, KH2P04 10,
HEPES 20, BSA 1%, K-MES 60 mM, sucrose 110 mM, pH 7.1, adjusted with 5 N KOH). Tissue was
homogenized for 3 s in 1 s bursts with a tissue homogenizer and loaded immediately (40 mg/ml) into
an Oroboros Oxygraph 2 k high resolution respirometry system (Oroboros Instruments, Innsbruck,
Austria) for measurement of mitochondrial respiration combined with the Fluorescence-Sensor
Green of the O2k-Fluo LED2-Module for H2O2 measurement (see Makrecka-Kuka et al., 2015 for
full details).
Two identical respiration chambers (chamber A and chamber B) held at the same temperature
were run in parallel for each experimental run. All measurements of respiration rates were carried
out at 37˚C. Oxygen electrodes were calibrated daily with air-saturated respiration solution Zero cali-
brations were achieved by injecting yeast into the experimental chambers. Oxygen solubility in the
assay medium was calculated as described previously (Lienig and Forstner, 1984). H2O2 flux was
measured simultaneously with respiration in the O2k-Fluorometer using the H2O2-sensitive probe
Amplex UltraRed (10 mM) with 1 U/mL horse radish peroxidase (HRP) and 5 U/mL superoxide dismu-
tase (SOD). AmR in the presence of H2O2 is catalysed by HRP to the fluorescent product resorufin.
Calibrations were performed with two sequential injections of H2O2 at 0.1 mM steps.
Three parameters are commonly used to assess mitochondrial function (for reviews, see
Brand and Nicholls, 2011; Pesta and Gnaiger, 2012). Firstly, the capacity for oxidative phosphory-
lation (OXPHOS) is the respiratory capacity of mitochondria in the ADP-activated state of oxidative
phosphorylation (saturating concentrations of ADP, inorganic phosphate, oxygen, and defined sub-
strates). Secondly, LEAK respiration rate represents mitochondrial respiration that occurs in the
absence of ATP generation, mainly to compensate for proton leak across the mitochondrial inner
membrane. Lastly, the respiratory electron transfer-pathway capacity (ETC) is mitochondrial respira-
tion in the noncoupled state in the presence an uncoupler; this induces maximum oxygen flux
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through the electron transport chain. The Respiratory Control Ratio (RCR, calculated here as
OXPHOS/LEAK) provides a measure of the degree of coupling between oxidation and phosphoryla-
tion, or in other words, the efficiency of mitochondrial ATP production.
OXPHOS, LEAK and ETS were measured in the presence of Complex I substrates pyruvate and
malate (electron transfer through Complexes I-IV) or Complex I+II substrates (addition of succinate).
Additionally, respiratory flux with electron transfer through Complex IV alone was measured via the
addition of the electron donor tetramethyl-phenylene-diamine (TMPD). The protocol used to mea-
sure these parameters was adapted from Pesta and Gnaiger (2012). Briefly, pyruvate (5 mmol l  1),
malate (0.25 mmol l 1) and glutamate (10 mmol l 1) are added as carbon substrates and to spark
the citric acid cycle. Under these conditions, mitochondria are in LEAK respiration with CI substrates
in the absence of adenylates. OXPHOS with CI substrates was achieved through addition of saturat-
ing levels of ADP (2 mM l 1). Following steady-state conditions, succinate (10 mmol l 1) was added
to achieve OXPHOS with CI+CII substrates. To uncouple respiration and achieve ETS with CI+CII
substrates, carbonyl cyanide 4-trifluoromethoxyphenylhydrazone (FCCP) was carefully titrated to a
maximum concentration of 0.25 mmol l 1. Rotenone was then added to achieve ETS with CII sub-
strates and antimycin A (5 mmol l 1) was given to block Complex III and measure background non-
mitochondrial residual oxygen consumption (ROX). OXPHOS through Complex IV alone was
assessed by adding the electron donor TMPD (0.5 mmol l 1). To avoid oxidation of TMPD, ascorbate
(2 mMol l 1) was added prior to TMPD injection.
Citrate synthase assay
The citrate synthase activity of cardiac homogenates were measured in frozen homogenates. Briefly,
maximal activity (Vmax) was determined with a spectrophotometer at 37˚C with a Synergy HTX spec-
trophotometer (BioTek, UK) in assay buffer; 50 mM TRIS-HCl, pH 8.0. Citrate synthase activity was
monitored in the presence or absence of oxaloacetate by the appearance of 5-thio-2-nitrobenzoic
acid as a result of the reaction of free acetyl-CoA with 5,5’-dithiobis(2-nitrobenzoic acid) at 412 nm
over a 10 min incubation period (assay buffer with 0.5 oxaloacetate, 0.3 mM acetyl-CoA, 0.15 mM
5,5-dithiobis-2-nitrobenzoic acid). Extinction coefficients were empirically determined to quantify
Vmax values. Enzyme activities were normalised to total soluble protein, which was quantified
according to Bradford (Bradford, 1976).
Western blots
Total cell protein was isolated from cells using protein extraction buffer (50 mM Tris, 150 mM NaCl,
1% TritonX-100, supplemented with protease inhibitors). Total protein was isolated from snap-frozen
tissue using RIPA buffer supplemented with protease inhibitor cocktail after disruption using Lysing
Matrix D tubes (MP Bio).
Electron Microscopy
All experiments were performed according to current UK Home Office regulations and under
approval of the relevant University of Manchester (Manchester, UK) local ethics committee.
Six mice were used for this study (n = 3 control, n = 3 Bud 23 KO). Immediately after euthanasia,
hearts were harvested and small portions (cubes with sides smaller than 0.5 mm) of right and left
ventricle were immersion fixed in 2.5% glutaraldehyde and 2% paraformaldehyde in 100 mM sodium
cacodylate buffer (pH 7.2) overnight. Specimen preparation was performed, with small modifica-
tions, according to the Ellisman protocol (Holcomb et al., 2013). Briefly, after washings in sodium
cacodylate, samples were sequentially stained in: 2% osmium tetroxide and 1.5% potassium ferrocy-
anide in 100 mM sodium cacodylate for 1 hr; 1% aqueous thiocarbohydrazide for 20 min; 2% aque-
ous osmium for 30 min; 1% aqueous uranyl acetate overnight and Walton’s lead aspartate for 30 min
the following morning at 60˚C. Samples were washed 3 times for 10 min in double distilled water
after each staining step. Staining was followed by dehydration in ethanol ascending series (50%,
70%, 90%, 100%) and infiltration with TAAB 812 hard resin mixed with propylene oxide. After
embedding, resin blocks were cured at 70˚ C for 40 hr. Plastic blocks were sectioned at 80 nm thick-
ness using a Leica UC6 ultramicrotome and sections were imaged using a FEI Tecnai12 Biotwin oper-
ated at 100kV. Images were analysed using Fiji (Schindelin et al., 2012).
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Cell fractionation
Fractionation experiments were performed by differential centrifugation as previously described pre-
viously (Rorbach et al., 2014).
Data analysis and statistics
Unless otherwise stated in the figure legend, parametric data was analysed by ANOVA with a Dun-
nett’s multiple comparisons test. Non-parametric data was analysed using a Mann-Whitney test.
RNAseq data was analysed using edgeR (Robinson et al., 2010). For Mass Spectrometry data analy-
sis please refer to the dedicated section.
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